Generative AI for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations - an ISPOR Working Group Report.

Autor: Fleurence RL; Office of the Director, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, United States. Electronic address: Rachael.fleurence@nih.gov., Bian J; Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Biomedical Informatics, Clinical and Translational Science Institute, University of Florida, Office of Data Science and Research Implementation, University of Florida Health, Gainesville, FL, United States., Wang X; Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, Intelligent Medical Objects, Rosemont, IL, United States., Xu H; Department of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT, United States., Dawoud D; National Institute for Health and Care Excellence, London, United Kingdom; Cairo University, Faculty of Pharmacy, Cairo, Egypt., Higashi M; ISPOR - The Professional Society for Health Economics and Outcomes Research, Lawrenceville, NJ, United States., Chhatwal J; Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Center for Health Decision Science, Harvard University, Boston, MA, United States.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.

Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.

Autor: Fleurence RL; Office of the Director, National Institutes of Health, Bethesda, MD, USA. Electronic address: rachael.fleurence@nih.gov., Kent S; Erasmus School of Health & Policy Management, Erasmus University, Rotterdam, The Netherlands., Adamson B; Flatiron Health, New York, NY, USA., Tcheng J; Duke University, Durham, NC, USA., Balicer R; Clalit Health Services, Tel-Aviv, Israel., Ross JS; Yale School of Medicine, Yale University, New Haven, CT, USA., Haynes K; Janssen Research and Development, Titusville, NJ, USA., Muller P; Centre for Guidelines, National Institute for Health and Care Excellence, Manchester or London, England, UK., Campbell J; National Pharmaceutical Council, Washington, DC, USA., Bouée-Benhamiche E; Public Health and Healthcare Division, Institut National du Cancer, Boulogne-Billancourt, France., García Martí S; Health Technology Assessment and Health Economics Department, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina., Ramsey S; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: sramsey@fredhutch.org.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Jun; Vol. 27 (6), pp. 692-701.

A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.

Autor: Fleurence RL; Executive Office of the President, The White House, Washington, DC., Collins FS; Executive Office of the President, The White House, Washington, DC.

Publikováno v: JAMA [JAMA] 2023 Apr 18; Vol. 329 (15), pp. 1251-1252.

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative.

Autor: Tromberg BJ; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Schwetz TA; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Pérez-Stable EJ; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Hodes RJ; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Woychik RP; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Bright RA; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Fleurence RL; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD., Collins FS; From the National Institute of Biomedical Imaging and Bioengineering (B.J.T.), the National Institute of Nursing Research (T.A.S.), the Office of the Director (T.A.S., R.A.B., R.L.F., F.S.C.), the National Institute on Minority Health and Health Disparities (E.J.P.-S.), the National Institute on Aging (R.J.H.), and the National Institute of Environmental Health Sciences, National Toxicology Program (R.P.W.), National Institutes of Health, Bethesda, MD.

Publikováno v: The New England journal of medicine [N Engl J Med] 2020 Sep 10; Vol. 383 (11), pp. 1071-1077. Date of Electronic Publication: 2020 Jul 22.

FOUNTAIN: a modular research platform for integrated real-world evidence generation.

Autor: Oberprieler, Nikolaus G.¹ (AUTHOR) niki.oberprieler@bayer.com, Pladevall-Vila, Manel^2,3 (AUTHOR), Johannes, Catherine⁴ (AUTHOR), Layton, J. Bradley⁵ (AUTHOR), Golozar, Asieh⁶ (AUTHOR), Lavallee, Martin⁶ (AUTHOR), Liu, Fangfang⁷ (AUTHOR), Kubin, Maria⁷ (AUTHOR), Vizcaya, David⁸ (AUTHOR)

Publikováno v: BMC Medical Research Methodology. 10/1/2024, Vol. 24 Issue 1, p1-10. 10p.